Melatonin promotes microglia toward anti-inflammatory phenotype after spinal cord injury

Yue Guo1, Peng Zhang2, Haosen Zhao3

  • 1Department of Orthopedic, First Affiliated Hospital of Jinzhou Medical University, Jinzhou, China; Key Laboratory of medical tissue engineering, Jinzhou Medical University, Jinzhou, P. R. China.

Insights

Melatonin shifts microglia from harmful to helpful, reducing inflammation and improving cell function in spinal cord injury models. This suggests melatonin as a potential therapy for neurological disorders.

Area of Science:

  • Neuroscience
  • Immunology
  • Cell Biology

Background:

  • Microglia are central nervous system immune cells involved in inflammation and tissue support.
  • Neurotoxic microglia in injured spinal cords impede spinal cord injury (SCI) repair.
  • Melatonin previously showed potential in suppressing SCI-induced neuronal inflammation.

Purpose of the Study:

  • To investigate the effect of melatonin on microglia responses in the context of SCI.
  • To determine if melatonin can modulate microglial polarization and function.

Main Methods:

  • Primary microglia and neurons were isolated and stimulated with inflammatory agents (LPS and IFN-γ) or melatonin.
  • Microglial polarization, reactive oxygen species (ROS) activity, and mitochondrial metabolism were assessed in vitro and in vivo.
  • Pro-inflammatory mRNA levels were quantified.

Main Results:

  • Melatonin promoted a shift from pro-inflammatory to anti-inflammatory microglial phenotypes.
  • Melatonin downregulated ROS production and restored mitochondrial metabolism.
  • Melatonin reduced the expression of pro-inflammatory genes.

Conclusions:

  • Melatonin exhibits neuroprotective effects by modulating microglial responses.
  • Melatonin demonstrates therapeutic potential for neuroinflammation-related conditions, including SCI.

Related Concept Videos